Latest Angioplasty Stories
Cardium Therapeutics' Generx product for patients myocardial ischemia and chest pains to be delivered noninvasively with standard angioplasty catheter to patients in Russia Cardium Therapeutics (NYSE Amex: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA. The new research findings demonstrate that cardiac ischemia...
SAN DIEGO, May 16, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA. (Photo: http://photos.prnewswire.com/prnh/20120516/LA07787) (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The new research findings demonstrate that cardiac ischemia plays...
TEL AVIV, Israel, May 10, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, will host a symposium and cocktail reception at the EuroPCR meeting on Wednesday, May 16 in Paris. Results from the EF (extended follow up) MAGICAL trial will be presented for the first time at this...
Post-PASSION trial analysis confirms no major adverse cardiac events New research confirms thrombus aspiration (TA) during percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) provides long-term outcomes similar to conventional intervention with bare-metal or drug-eluting stents. Findings published in a special STEMI-focused issue of Catheterization and Cardiovascular Interventions, a journal of the Society for Cardiovascular...
CAESAREA, Israel, May 2, 2012 /PRNewswire/ -- Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature. The new 3/100mm device accommodates 0.014" guide-wires, which significantly broadens the potential use of PROTEUS technology. Angioslide's proprietary technology combines the functionality...
Variation rates not fully explained by community rates for risk factors, heart attack, or cardiac mortality Regional differences in rates of cardiac procedures have increased in Michigan over the past decade—not fully explained by differences in health risk factors, heart attack or cardiac mortality rates—according to a report released today by the Center for Healthcare Research & Transformation (CHRT). The report compares the state's hospital referral regions (HRRs) using claims...
Variation rates not fully explained by community rates for risk factors, heart attack, or cardiac mortality ANN ARBOR, Mich., April 30, 2012 /PRNewswire-USNewswire/ -- Regional differences in rates of cardiac procedures have increased in Michigan over the past decade--not fully explained by differences in health risk factors, heart attack or cardiac mortality rates--according to a report released today by the Center for Healthcare Research & Transformation (CHRT). The report...
Peripheral artery disease, which covers problems in the arteries supplying the legs, arms and most organs, is often overlooked or misdiagnosed in women. Harvard Women's Health Watch offers tips for identifying and treating this all-too-common and potentially debilitating condition. Boston, MA (PRWEB) April 13, 2012 If ever a disease deserved a new name, peripheral artery disease is it. "Peripheral" smacks of something on the sidelines. Nothing could be further from the truth....
LAGUNA HILLS, Calif., April 12, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that veteran medical device sales and marketing executive Michael D. Gioffredi has been named Chief Commercialization Officer. Gioffredi has worked as an executive in the medical device industry for over 25 years and for the past six years served as Senior Vice President of...
JVIR Editor's Awards for 2011 Outstanding Clinical Research and Outstanding Laboratory Investigation Articles Presented During Society of Interventional Radiology's 37th Annual Scientific Meeting SAN FRANCISCO, March 28, 2012 /PRNewswire-USNewswire/ -- The Journal of Vascular and Interventional Radiology--the Society of Interventional Radiology's flagship publication--together with the SIR Foundation presented the 2011 JVIR Editor's Award for Outstanding Clinical Research Paper to...
Latest Angioplasty Reference Libraries
Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...
